PCMA Supports Bipartisan REMEDY Act to Reduce Drug Prices
April 12, 2019
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on bipartisan legislation introduced...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
PCMA: Greater Competition on Insulin Products Key to Reducing Prices
April 10, 2019
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) applauds the Energy and Commerce Subcommittee on Oversight and Investigations for...
Independent Drugstore Lobby Agenda Increases Prescription Drug Costs in Pennsylvania
April 09, 2019
(Washington, D.C.) — As independent drugstore lobbyists descend on Harrisburg for their lobby day, the Pharmaceutical Care Management Association (PCMA) released the...
April 09, 2019
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on today’s markup in...
PBMs Advocate for Consumers and Health Plans to Reduce Prescription Drug Costs
April 09, 2019
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott today released the following statement on the...
April 08, 2019
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the association’s...
New Analysis: HHS Proposed Rebate Rule ‘Poorly Conceived’
April 04, 2019
(Washington, D.C.) — The Health and Human Services (HHS) Office of Inspector General’s proposed rule on prescription drug rebates in...
PCMA Unveils New Campaign on the Value of Pharmacy Benefit Managers in Maine
March 28, 2019
(Washington, D.C.) — As the debate on prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for Maine...
PCMA Applauds Passage of Legislation to Curb Drug Manufacturer Patent Abuses
March 27, 2019
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on today’s vote...
March 18, 2019
(Washington, D.C.) — Senior registered voters enrolled in Medicare Part D will be less likely to support the reelection of...
Independent Drugstore Lobby Agenda Increases Prescription Drug Costs in Illinois
March 13, 2019
(Washington, D.C.) — As drugstore lobbyists today push their agenda in Springfield, the Pharmaceutical Care Management Association (PCMA) released the...
PCMA Unveils New Campaign on the Value of Pharmacy Benefit Managers in Texas
March 11, 2019
(Washington, D.C.) — As the debate on prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for Texas...